| Name | Title | Contact Details |
|---|
Encision Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Boulder, CO. To find more information about Encision Inc., please visit www.encision.com
The University of Vermont Medical Center is part of a six-hospital network serving patients and their families in Vermont and northern New York. We`re not just caregivers and staff - we`re your friends and neighbors, offering expertise, kind words and compassionate care when and where you need them. We are dedicated to providing you with the best medical care possible. The University of Vermont Medical Center, along with the Robert Larner M.D. College of Medicine The University of Vermont and College of Nursing and Health Sciences, is one of 138 academic medical centers in the country. Through The University of Vermont Health Network and collaborative relationships throughout Vermont and northern New York, we are able to provide the highest quality care, informed by academic research, to patients throughout our region. The UVM Medical Center, along with its three founding organizations, The University of Vermont College of Medicine and College of Nursing and Health Sciences, share a rich history dating back to the 1800s. The UVM Medical Center is committed to the development of an Integrated Delivery System which provides high value health care to the communities we serve and enhances our academic mission. Our mission is to improve the health of the people in the communities we serve by integrating patient care, education, and research in a caring environment.
Specialized Health Products International, Inc. is a Bountiful, UT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Jarvie Commonweal Service is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about Jarvie Commonweal Service, please visit www.jarvie.org
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.